Skip to content

Clinical trials

Phase 1 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1 Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20023
20036
20047
20055
20067
20078
20086
20094
20107
20114
20126
20136
201412
20159
20169
201712
201810
201911
202012
202112
202213
202320
202410
202519
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed118
Recruiting38
Terminated28
Unknown status25
Active, not recruiting23
Not yet recruiting11
Withdrawn9
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
M.D. Anderson Cancer Center6
Novartis Pharmaceuticals6
Chongqing Precision Biotech Co., Ltd5
Eli Lilly and Company5
Memorial Sloan Kettering Cancer Center5
Pfizer5
University Medical Center Groningen5
Washington University School of Medicine4
Anhui Provincial Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms255
Stomach Neoplasms128
Carcinoma, Non-Small-Cell Lung80
Pancreatic Neoplasms67
Breast Neoplasms65
Ovarian Neoplasms65
Colorectal Neoplasms64
Lung Neoplasms57
Melanoma42
Urinary Bladder Neoplasms42

Trials

Showing 51 to 75 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.